H3 Biomedicine Promotes Peter Smith to Chief Scientific Officer

Xconomy Boston — 

Peter Smith has been named chief scientific officer of H3 Biomedicine. Smith is currently vice president, Drug Discovery Biology, for the Cambridge, MA-based precision medicine oncology company. Before joining H3 Biomedicine in 2011, Smith held various roles in oncology discovery for Millennium Pharmaceuticals/Takeda Oncology. He starts in his new role at H3 Biomedicine on March 1.